Center-Authored Papers

Filters: Author is Doherty, Jennifer A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PDP, Chenevix-Trench G, Rossing MA, Cramer D, Pearce CL et al..  2014.  Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH et al..  2009.  Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.. British journal of cancer. 100(2):412-20. Abstract
U
Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS.  2009.  Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer.. American journal of epidemiology. 170(12):1512-7. Abstract
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, Defazio A, Risch HA, Rossing MA et al..  2017.  Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.. British journal of cancer. Abstract
T
Setiawan VW, Doherty JA, Shu X-O, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA et al..  2009.  Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(1):242-7. Abstract
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K et al..  2013.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.. International journal of epidemiology. 42(2):579-89. Abstract
Karami S, Han Y, Pande M, Cheng I, Rudd J, Pierce BL, Nutter EL, Schumacher FR, Kote-Jarai Z, Lindstrom S et al..  2016.  Telomere structure and maintenance gene variants and risk of five cancer types.. International journal of cancer. 139(12):2655-2670. Abstract
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS et al..  2016.  A targeted genetic association study of epithelial ovarian cancer susceptibility.. Oncotarget. 7(7):7381-7389. Abstract
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC et al..  2009.  Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.. British journal of cancer. 100(6):993-1001. Abstract
S
Bodelon C, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA.  2012.  Sun exposure and risk of epithelial ovarian cancer.. Cancer causes & control : CCC. 23(12):1985-94. Abstract
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J et al..  2016.  A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.. International journal of cancer. Abstract
Sakoda LC, Blackston CR, Doherty JA, Ray RM, Lin MG, Gao D, Stalsberg H, Feng Z, Thomas DB, Chen C.  2011.  Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.. Cancer epidemiology. 35(1):48-55. Abstract
R
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Clyde MA, Weber RP, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL et al..  2016.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.. American journal of epidemiology. 184(8):579-589. Abstract
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E et al..  2013.  Risk of Ovarian Cancer and the NF-κB Pathway: Genetic association with IL1A and TNFSF10.. Cancer research. Abstract
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS.  2008.  Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery.. Cancer causes & control : CCC. 19(10):1357-64. Abstract
Cannioto RA, Lamonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong C-C, Szender BJ, Sucheston-Campbell L, Joseph JM et al..  2016.  Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.. British journal of cancer. Abstract
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS.  2010.  Recreational physical activity and risk of epithelial ovarian cancer.. Cancer causes & control : CCC. 21(4):485-91. Abstract
Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjær SK, Chang-Claude J, Köbel M et al..  2013.  Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.. BMC cancer. 13:28. Abstract
P
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC et al..  2011.  Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):1028-31. Abstract
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL et al..  2011.  Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.. Fertility and sterility. 95(1):40-5. Abstract
Pocobelli G, Doherty JA, Voigt LF, Beresford SAA, Hill DA, Chen C, Rossing MA, Holmes RS, Noor ZS, Weiss NS.  2011.  Pregnancy history and risk of endometrial cancer.. Epidemiology (Cambridge, Mass.). 22(5):638-45. Abstract
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN et al..  2015.  Population distribution of lifetime risk of ovarian cancer in the United States.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(4):671-6. Abstract
Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM, Goode EL, Rider DN, Vierkant RA, Anderson S et al..  2009.  Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.. Twin research and human genetics : the official journal of the International Society for Twin Studies. 12(3):269-75. Abstract
Sakoda LC, Blackston C, Doherty JA, Ray RM, Lin MG, Stalsberg H, Gao D, Feng Z, Thomas DB, Chen C.  2008.  Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(5):1066-73. Abstract